FDA Determines Regulatory Review Period for APTHERA INTRAOCULAR LENS Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the extension of a patent for the IC-8 APTHERA INTRAOCULAR LENS, following a submission to the US Patent and Trademark Office (USPTO).